The Broader Significance of a New Drug for a Rare Form of ALS

15. May 2023 Health 0
The Broader Significance of a New Drug for a Rare Form of ALS

(MedPage Today) — A major milestone in the treatment of amyotrophic lateral sclerosis (ALS) occurred on April 25, 2023, when the FDA approved tofersen (Qalsody) for patients carrying the disease-causing mutation superoxide dismutase 1 (SOD1)…

Powered by WPeMatico